Update: Surgical management of breast cancer: Today and tomorrow

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The surgeon continues to play a key role in the initial local/regional management of breast cancer. Breast conserving therapy (BCT) utilizing segmental mastectomy has been developed as an alternative to total mastectomy to improve cosmetic and psychosocial outcomes while retaining oncologic benefits. Developments in the surgical treatment of breast cancer have changed the way breast cancer is diagnosed and treated, and will likely continue to evolve in the future. This review highlights aspects of breast cancer treatment in which the surgical approach has evolved or is evolving, and comments on how the surgeon may participate in breast cancer care in the future.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalCancer Biotherapy and Radiopharmaceuticals
Volume17
Issue number1
StatePublished - 2002

Fingerprint

Breast Neoplasms
Simple Mastectomy
Segmental Mastectomy
Cosmetics
Breast
Therapeutics
Surgeons

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Oncology

Cite this

Update : Surgical management of breast cancer: Today and tomorrow. / Bold, Richard J.

In: Cancer Biotherapy and Radiopharmaceuticals, Vol. 17, No. 1, 2002, p. 1-9.

Research output: Contribution to journalArticle

@article{04182396cf874a1c89d7bbf48178d255,
title = "Update: Surgical management of breast cancer: Today and tomorrow",
abstract = "The surgeon continues to play a key role in the initial local/regional management of breast cancer. Breast conserving therapy (BCT) utilizing segmental mastectomy has been developed as an alternative to total mastectomy to improve cosmetic and psychosocial outcomes while retaining oncologic benefits. Developments in the surgical treatment of breast cancer have changed the way breast cancer is diagnosed and treated, and will likely continue to evolve in the future. This review highlights aspects of breast cancer treatment in which the surgical approach has evolved or is evolving, and comments on how the surgeon may participate in breast cancer care in the future.",
author = "Bold, {Richard J}",
year = "2002",
language = "English (US)",
volume = "17",
pages = "1--9",
journal = "Cancer Biotherapy and Radiopharmaceuticals",
issn = "1084-9785",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Update

T2 - Surgical management of breast cancer: Today and tomorrow

AU - Bold, Richard J

PY - 2002

Y1 - 2002

N2 - The surgeon continues to play a key role in the initial local/regional management of breast cancer. Breast conserving therapy (BCT) utilizing segmental mastectomy has been developed as an alternative to total mastectomy to improve cosmetic and psychosocial outcomes while retaining oncologic benefits. Developments in the surgical treatment of breast cancer have changed the way breast cancer is diagnosed and treated, and will likely continue to evolve in the future. This review highlights aspects of breast cancer treatment in which the surgical approach has evolved or is evolving, and comments on how the surgeon may participate in breast cancer care in the future.

AB - The surgeon continues to play a key role in the initial local/regional management of breast cancer. Breast conserving therapy (BCT) utilizing segmental mastectomy has been developed as an alternative to total mastectomy to improve cosmetic and psychosocial outcomes while retaining oncologic benefits. Developments in the surgical treatment of breast cancer have changed the way breast cancer is diagnosed and treated, and will likely continue to evolve in the future. This review highlights aspects of breast cancer treatment in which the surgical approach has evolved or is evolving, and comments on how the surgeon may participate in breast cancer care in the future.

UR - http://www.scopus.com/inward/record.url?scp=0036480433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036480433&partnerID=8YFLogxK

M3 - Article

C2 - 11915165

AN - SCOPUS:0036480433

VL - 17

SP - 1

EP - 9

JO - Cancer Biotherapy and Radiopharmaceuticals

JF - Cancer Biotherapy and Radiopharmaceuticals

SN - 1084-9785

IS - 1

ER -